SCHEMBL15022065

SCHEMBL15022065

Cn1cc(-c2ccncc2)c(-c2ccc(C#C[Si](C)(C)C)cn2)n1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 8/20 0.49
MAPK13 O15264 1/20 0.46
CSNK1D P48730 1/20 0.46
CSNK1E P49674 1/20 0.46
MAPK12 P53778 1/20 0.46
MAPK11 Q15759 1/20 0.46
MAPK14 Q16539 1/20 0.46
BRAF P15056 9/20 0.46
MAPK3 P27361 3/20 0.42
MAPK1 P28482 3/20 0.42
GRM5 P41594 1/20 0.39
MAP4K4 O95819 1/20 0.39
EGFR P00533 1/20 0.39
FRK P42685 1/20 0.39
MAPK9 P45984 1/20 0.39
CSNK1A1 P48729 1/20 0.39
LGALS3 P17931 1/20 0.39
PDE4D Q08499 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15022080 0.84 PDE10A (0.49) PDE10AMAPK13CSNK1DCSNK1EMAPK12
SCHEMBL15022077 0.84 PDE10A (0.63) PDE10AMAPK13CSNK1DCSNK1EMAPK12
SCHEMBL15023023 0.78 PDE10A (0.52) PDE10AGRM5LGALS3PDE4D
SCHEMBL15022103 0.78 MAPK13 (0.51) PDE10AMAPK13CSNK1DCSNK1EMAPK12
SCHEMBL15022322 0.77 CSNK1D (0.52) PDE10AMAPK13CSNK1DCSNK1EMAPK12
SCHEMBL15022345 0.77 MAPK13 (0.53) PDE10AMAPK13CSNK1DCSNK1EMAPK12
SCHEMBL15022260 0.76 MAP4K4 (0.66) PDE10AMAPK13CSNK1DCSNK1EMAPK12
SCHEMBL27924985 0.75 CSNK1D (0.47) PDE10AMAPK13CSNK1DCSNK1EMAPK12
SCHEMBL27924982 0.74 MAPK13 (0.46) PDE10AMAPK13CSNK1DCSNK1EMAPK12
SCHEMBL27907019 0.72 MAPK14 (0.56) PDE10AMAPK13CSNK1DCSNK1EMAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 US disclosed
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 US disclosed
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF CHRNA10, ATXN10, SCN10A PDE10A 5/4885MAPK13 2559/4885CSNK1D 2512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.